Abstract: The present invention provides 6-substituted pyridazine compounds of formula (I), which are therapeutically useful as SMARCA2 and/or SMARCA4 degraders. These compounds are useful in the treatment and/or delaying progression of diseases or disorders dependent upon SMARCA2 and/or SMARCA4 in a subject. The present invention also provides preparation of the compounds and pharmaceutical compositions comprising at least one of the compounds of formula (I) or a pharmaceutically acceptable salt, or a stereoisomer or a tautomer or a prodrug thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202347013810.pdf | 2023-03-01 |
| 2 | 202347013810-STATEMENT OF UNDERTAKING (FORM 3) [01-03-2023(online)].pdf | 2023-03-01 |
| 3 | 202347013810-FORM 1 [01-03-2023(online)].pdf | 2023-03-01 |
| 4 | 202347013810-DECLARATION OF INVENTORSHIP (FORM 5) [01-03-2023(online)].pdf | 2023-03-01 |
| 5 | 202347013810-COMPLETE SPECIFICATION [01-03-2023(online)].pdf | 2023-03-01 |
| 6 | 202347013810-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [01-03-2023(online)].pdf | 2023-03-01 |
| 7 | 202347013810-Proof of Right [04-08-2023(online)].pdf | 2023-08-04 |
| 8 | 202347013810-FORM 3 [11-08-2023(online)].pdf | 2023-08-11 |
| 9 | 202347013810-FORM 3 [07-02-2024(online)].pdf | 2024-02-07 |
| 10 | 202347013810-FORM 18 [30-07-2024(online)].pdf | 2024-07-30 |
| 11 | 202347013810-FORM 3 [31-07-2024(online)].pdf | 2024-07-31 |